Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2008-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2008.02.016PMID 18308574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.

  2008cited by this paper
• Synthesis of fluorescently tagged isoprenoid bisphosphonates that inhibit protein geranylgeranylation.

  2007cited by this paper
• Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.

  2007cited by this paper
• Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases

  2007cited by this paper
• The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs

  2006cited by this paper
• Cytosolic Entry of Bisphosphonate Drugs Requires Acidification of Vesicles after Fluid-Phase Endocytosis

  2006cited by this paper
• Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells

  2006cited by this paper
• Activity of nitrogen-containing and non-nitrogen-containing bisphosphonates on tumor cell lines.

  2006cited by this paper
• The Crystal Structure of Human Geranylgeranyl Pyrophosphate Synthase Reveals a Novel Hexameric Arrangement and Inhibitory Product Binding*

  2006cited by this paper
• Synthesis and biological activity of isoprenoid bisphosphonates.

  2006cited by this paper
• Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs

  2006cited by this paper
• Discovery, Clinical Development, and Therapeutic Uses of Bisphosphonates

  2005cited by this paper
• Copper-mediated displacements of allylic THP ethers on a bisphosphonate template

  2005cited by this paper
• Quantitative Structure-Activity Relationships for γδ T Cell Activation by Bisphosphonates

  2004cited by this paper
• Nitrogen-containing bisphosphonate mechanism of action.

  2004cited by this paper
• Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.

  2004cited by this paper
• Bisphosphonate prodrugs.

  2002cited by this paper
• Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.

  2002cited by this paper
• In Vivo Activities of Farnesyl Pyrophosphate Synthase Inhibitors against Leishmania donovani and Toxoplasma gondii

  2002cited by this paper
• Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

  2001cited by this paper
• Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.

  2001cited by this paper
• Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI‐298

  2000cited by this paper
• A peptide prodrug approach for improving bisphosphonate oral absorption.

  2000cited by this paper
• Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.

  2000cited by this paper
• Bisphosphonate prodrugs: synthesis and in vitro evaluation of alkyl and acyloxymethyl esters of etidronic acid as bioreversible prodrugs of etidronate.

  2000cited by this paper
• Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma

  2000cited by this paper
• Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.

  2000cited by this paper
• The Role of Geranylgeranylation in Bone Resorption and Its Suppression by Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen‐Containing Bisphosphonates

  1999cited by this paper
• Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo.

  1999cited by this paper
• Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.

  1999cited by this paper
• Bisphosphonate prodrugs: synthesis and in vitro evaluation of novel clodronic acid dianhydrides as bioreversible prodrugs of clodronate.

  1999cited by this paper
• Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.

  1998cited by this paper
• Estimation of Oral Bioavailability of a Long Half-Life Drug in Healthy Subjects

  1998cited by this paper
• Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase.

  1998cited by this paper
• Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti‐tumour activity

  1997cited by this paper
• Inhibition of Growth of Dictyostelium discoideum Amoebae by Bisphosphonate Drugs Is Dependent on Cellular Uptake

  1997cited by this paper
• Metabolism and Pharmacokinetics of Novel Oral Prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in Dogs

  1997cited by this paper
• Estimation of the Relative Contribution of the Transcellular and Paracellular Pathway to the Transport of Passively Absorbed Drugs in the Caco-2 Cell Culture Model

  1997cited by this paper
• Bisphosphonates: a review of their pharmacokinetic properties.

  1996cited by this paper
• Structural requirements for bisphosphonate actions in vitro

  1994cited by this paper
• Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.

  1993cited by this paper
• Prodrugs for the improvement of drug absorption via different routes of administration

  1990cited by this paper
• Paracellular transport of inorganic and organic ions across the rat ileum.

  1983cited by this paper
• Determination of formation constants of calcium complexes of difluoromethylenediphosphonic acid and related diphosphonates

  1983cited by this paper

• Impact of fixed phosphorus position on activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.

  2025cites this paper
• Synthesis and preliminary anticancer evaluation of photo-responsive prodrugs of hydroxymethylene bisphosphonate alendronate.

  2024cites this paper
• Lanosterol biosynthesis pathway in GtoPdb v.2023.1

  2023cites this paper
• Prodrugs of pyrophosphates and bisphosphonates: disguising phosphorus oxyanions

  2022cites this paper
• Challenging synthesis of bisphosphonate derivatives with reduced steric hindrance

  2021cites this paper
• Diketopyrrolopyrrole Bis-Phosphonate Conjugate: A New Fluorescent Probe for In Vitro Bone Imaging.

  2019cites this paper
• Synthesis of asymmetric phosphonate prodrugs

  2019cites this paper
• Lanosterol biosynthesis pathway (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Functional bisphosphonate synthesis for the development of new anti-resorption bone drug candidates

  2019cites this paper
• Phosphonate prodrugs: an overview and recent advances.

  2019cites this paper
• Regulation of the Notch-ATM-abl axis by geranylgeranyl diphosphate synthase inhibition

  2019cites this paper
• Title Anti-Tumor Activity and Immunotherapeutic Potential of aBisphosphonate Prodrug

  2018cites this paper
• α-Methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.

  2018cites this paper
• Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug

  2017cites this paper
• Pyrrolidine-Containing Bisphosphonates as Potential Anti-Resorption Bone Drugs.

  2017cites this paper
• Activation of Human Vγ9Vδ2 T Cells by Phosphoantigen Prodrugs

  2017cites this paper
• Nitrile Containing Bisphosphonates: Easy Synthesis through Metal Catalyzed Michael Addition

  2017cites this paper
• Stereoselective Synthesis of Chiral Isatin Containing Bisphosphonates as Potential Anti‐Resorption Bone Drugs

  2017cites this paper
• Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors

  2017cites this paper
• Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

  2016cites this paper
• Evaluation of a 7‐Methoxycoumarin‐3‐carboxylic Acid Ester Derivative as a Fluorescent, Cell‐Cleavable, Phosphonate Protecting Group

  2016cites this paper
• Targeting Cancer Cells with a Bisphosphonate Prodrug

  2016cites this paper
• A new motif for inhibitors of geranylgeranyl diphosphate synthase.

  2016cites this paper
• Stereocontrolled regeneration of olefins from epoxides.

  2016cites this paper
• Potent Triazole Bisphosphonate Inhibitor of Geranylgeranyl Diphosphate Synthase.

  2015cites this paper
• Synthesis and Biological Evaluation of a Phosphonate Phosphoantigen Prodrug

  2015cites this paper
• In vitro studies in a myelogenous leukemia cell line suggest an organized binding of geranylgeranyl diphosphate synthase inhibitors.

  2015cites this paper
• Solventless synthesis of acyl phosphonamidates, precursors to masked bisphosphonates.

  2015cites this paper
• Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.

  2014cites this paper
• Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes.

  2014cites this paper
• Synthesis of isoprenoid bisphosphonate ethers through C–P bond formations: Potential inhibitors of geranylgeranyl diphosphate synthase

  2014cites this paper
• Copper‐mediated 1,4‐Conjugate Addition of Boronic Acids and Indoles to Vinylidenebisphosphonate leading to gem‐Bisphosphonates as Potential Antiresorption Bone Drugs

  2014cites this paper
• Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.

  2013cites this paper
• An alternative pathway to ribonucleoside β-hydroxyphosphonate analogues and related prodrugs.

  2013cites this paper
• Quantitative determination of isopentenyl diphosphate in cultured mammalian cells.

  2013cites this paper
• Water enhanced synthesis of gem-bisphosphonates via Rh(I) mediated 1,4-conjugate addition of aryl boronic acids to vinylidenebisphosphonate esters

  2013cites this paper
• Triazole-based inhibitors of geranylgeranyltransferase II.

  2013cites this paper
• Synthesis, characterization and biological activity of hydroxyl-bisphosphonic analogs of bile acids.

  2012cites this paper
• Preparation of mixed trialkyl alkylcarbonate derivatives of etidronic acid via an unusual route

  2012cites this paper
• Analogues of Hybrid Antimicrobial Peptide, CAMA-P2, Designed with Improved Antimicrobial and Synergistic Activities

  2011cites this paper
• Novel bisphosphonates as inhibitors of isoprenoid biosynthesis

  2011cites this paper
• Inhibition of Farnesyl and Geranylgeranyl Diphosphate Synthases

  2011cites this paper
• Chapter 5 – Chemical Probes of Protein Prenylation

  2011cites this paper
• Bisphosphonamidate clodronate prodrug exhibits potent anticancer activity in non-small-cell lung cancer cells.

  2011cites this paper
• Geranylgeranyl Diphosphate Synthase: An Emerging Therapeutic Target

  2011cites this paper
• Geranylgeranyl diphosphate depletion inhibits breast cancer cell migration

  2011cites this paper
• A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro[S]

  2011cites this paper
• Flavonoid Inhibitors of β-Ketoacyl Acyl Carrier Protein Synthase III against Methicillin-Resistant Staphylococcus aureus

  2011cites this paper
• Lipophilic pyridinium bisphosphonates: potent gammadelta T cell stimulators.

  2010cites this paper
• Mixed 1,1-bisphosphorus compounds: synthesis, alkylation, and Horner-Wadsworth-Emmons olefination reactions.

  2010cites this paper
• Synthesis and biological evaluation of a series of aromatic bisphosphonates.

  2010cites this paper
• Isoprenoid metabolism as a therapeutic target in gram-negative pathogens.

  2010cites this paper
• Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics.

  2009cites this paper
• The intermediate enzymes of isoprenoid metabolism as anticancer targets.

  2009cites this paper
• Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue.

  2008cites this paper